Wan Mohd Nazlee Wan Zainon

Wan Mohd Nazlee Wan Zainon

Auto-generated profile, based on publicly available information

Wan Mohd Nazlee Wan Zainon

Department of Family Medicine, Hospital Universiti Sains Malaysia, Kota Bharu, Malaysia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2020 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
MRMohd Fazrin Mohd Rohani
Mohd Fazrin Mohd Rohani
SYSiti Nurshahirah Mohd Yonan
Siti Nurshahirah Mohd Yonan
NTNashrulhaq Tagiling
Nashrulhaq Tagiling
WZWan Mohd Nazlee Wan Zainon
Wan Mohd Nazlee Wan Zainon
YUYusri Udin
Yusri Udin
NNNorazlina Mat Nawi
Norazlina Mat Nawi
Study DesignRetrospective study.PurposeThis study aims to semiquantitatively evaluate the standardized uptake value (SUV) of 99mTc-methylene diphosphonate (MDP) radionuclide tracer in the normal vertebrae of breast cancer patients using an integrated single-photon emission computed tomography (SPECT)/computed tomography (CT) scanner.Overview of LiteratureMolecular imaging techniques using gamma cameras and stand-alone SPECT have traditionally been utilized to evaluate metastatic bone diseases. However, these methods lack quantitative analysis capabilities, impeding accurate uptake characterization.MethodsA total of 30 randomly selected female breast cancer patients were enrolled in this study. The SUV mean (SUVmean) and SUV maximum (SUVmax) values for 286 normal vertebrae at the thoracic and lumbar levels were calculated based on the patients’ body weight (BW), body surface area (BSA), and lean body mass (LBM). Additionally, 106 degenerative joint disease (DJD) lesions of the spine were also characterized, and both their BW SUVmean and SUVmax values were obtained. A receiver operating characteristic (ROC) curve analysis was then performed to determine the cutoff value of SUV for differentiating DJD from normal vertebrae.ResultsThe mean±standard deviations for the SUVmean and SUVmax in the normal vertebrae displayed a relatively wide variability: 3.92±0.27 and 6.51±0.72 for BW, 1.05±0.07 and 1.75±0.17 for BSA, and 2.70±0.19 and 4.50±0.44 for LBM, respectively. Generally, the SUVmean had a lower coefficient of variation than the SUVmax. For DJD, the mean±standard deviation for the BW SUVmean and SUVmax was 5.26±3.24 and 7.50±4.34, respectively. Based on the ROC curve, no optimal cutoff value was found to differentiate DJD from normal vertebrae.ConclusionsIn this study, the SUV of 99mTc-MDP was successfully determined using SPECT/CT. This research provides an approach that could potentially aid in the clinical quantification of radionuclide uptake in normal vertebrae for the management of breast cancer patients.

30 June 2024 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
SSS. Thadchaiani Saminathan
S. Thadchaiani Saminathan
WAWan Aireene Wan Ahmed
Wan Aireene Wan Ahmed
NNNorazlina Mat Nawi
Norazlina Mat Nawi
NTNashrulhaq Tagiling
Nashrulhaq Tagiling
IAIlyana Aziz
Ilyana Aziz
MRMohammad Khairul Azhar Abdul Razab
Mohammad Khairul Azhar Abdul Razab
Study Design: Retrospective study.Purpose: To compare and correlate technetium-99m methylene diphosphonate uptake between benign and metastatic bone lesions using semiquantitative analysis of maximum standard uptake value (SUVmax) and mean Hounsfield unit (HU) in single-photon emission computed tomography-computed tomography (SPECT-CT).Overview of Literature: Qualitative interpretation of metastatic bone lesions in breast cancer on bone scintigraphy is often complicated by coexisting benign lesions.Methods: In total, 185 lesions were identified on bone and SPECT-CT scans from 32 patients. Lesions were classified as metastatic (109 sclerotic lesions) and benign (76 lesions) morphologically on low-dose CT. Semiquantitative analysis using SUVmax and mean HU was performed on the lesions and compared. To discriminate benign and metastatic lesions, the correlation between SUVmax and mean HU was determined using the intraclass correlation coefficients.Results: The SUVmax was higher in metastatic lesions (20.66±14.36) but lower in benign lesions (10.18±12.79) (p<0.001). The mean HU was lower in metastatic lesions (166.62±202.02) but higher in benign lesions (517.65±192.8) (p<0.001). A weak negative correlation was found between the SUVmax and the mean HU for benign lesions, and a weak positive correlation was noted between the SUVmax and the mean HU on malignant lesions with no statistical significance (p=0.394 and 0.312, respectively). The cutoff values obtained were 10.8 for SUVmax (82.6% sensitivity and 84.2% specificity) and 240.86 for the mean HU (98.7% sensitivity and 88.1% specificity) in differentiating benign from malignant bone lesions.Conclusions: Semiquantitative assessment using SUVmax and HU can complement qualitative analysis. Metastatic lesions had higher SUVmax but lower mean HU than benign lesions, whereas benign lesions demonstrated higher mean HU but lower SUVmax. A weak correlation was found between the SUVmax and the mean HU on malignant and benign lesions. Cutoff values of 10.8 for the SUVmax and 240.86 for the mean HU may differentiate bone metastases from benign lesions.

5 May 2024 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NTNashrulhaq Tagiling
Nashrulhaq Tagiling
IIIzleen Laili Ibrahim
Izleen Laili Ibrahim
Yeong Yeh LeeYeong Yeh Lee
Yeong Yeh Lee
MUMuhamad Yusri Udin
Muhamad Yusri Udin
MKMohamad Dzulhilmi Mohamad Kamarulzaman
Mohamad Dzulhilmi Mohamad Kamarulzaman
NNNorazlina Mat Nawi
Norazlina Mat Nawi

24 September 2021 in Egyptian Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
WZWan Mohd Nazlee Wan Zainon
Wan Mohd Nazlee Wan Zainon
WRWan Faiziah Wan Abdul Rahman
Wan Faiziah Wan Abdul Rahman
MYMaya Mazuwin Yahya
Maya Mazuwin Yahya
NNNor Azwani Mat Nawi
Nor Azwani Mat Nawi
NSNurul Shamimi Suhaimi
Nurul Shamimi Suhaimi
Background: In cases of papillary thyroid carcinoma (PTC), lymph nodes are a typical site of metastasis. Extrathyroidal tissue involvement in differentiated thyroid carcinoma causes the disease to progress and affects the patients’ treatment options. Papillary thyroid carcinoma (PTC) is the common type in differentiated thyroid carcinoma (DTC), the other type is follicular thyroid carcinoma (FTC). Ectopic sites, such as intrathyroidal lymph node invasion in classical papillary thyroid malignancy, are extremely uncommon. It can be difficult to detect an intrathyroidal lymph node (ITLN) during a histopathological test, but it is important to do so since it affects the stage of the disease and subsequent treatment. Case presentation: We present the case of a 63-year-old woman who presented with multinodular goitre and underwent total thyroidectomy. She was diagnosed with aberrant intrathyroidal lymph node metastases during pathological testing, resulting in an upgrade in treatment. Owing to the exceptionally unusual ectopic position of lymph node metastasis, in this case, there is a risk of diagnostic and therapeutic misinterpretation. This patient was treated with high-dose radioactive iodine in view of lymph node metastases. Conclusions: Identification of ITLN by imaging characteristics is sometimes difficult, being often an intraoperative discovery and histopathological correlation that lead to upstage the disease and alter the final management.